Scottsdale, AZ – According to filings with the U.S. Securities and Exchange Commission, Journey Medical is raising $30,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Claude Maraoui played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Journey Medical
Journey Medical Corporation (Journey) is an innovative company focused on developing, acquiring, licensing, and commercializing branded dermatology products. Journeys team is comprised of industry experts with decades of experience commercializing some of the most successful dermatology products in the prescription pharmaceutical industry. Journey is a subsidiary of Fortress Biotech, Inc. Journeys core purpose is to positively impact peoples lives and well-being by providing effective solutions for treating skin conditions, healing wounds and supporting healthy skin.

To learn more about Journey Medical, visit http://journeymedicalcorp.com/

Contact:
Claude Maraoui, Chief Executive Officer
480-434-6670
https://www.linkedin.com/in/claudemaraoui/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved